Eton Pharmaceuticals, Inc. financial data

Symbol
ETON on Nasdaq
Industry
Pharmaceutical Preparations
Location
21925 W. Field Parkway, Suite 235, Deer Park, IL
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165 % -27.7%
Quick Ratio 29.5 % +301%
Debt-to-equity 152 % +58.4%
Return On Equity -22.1 % -255%
Return On Assets -8.76 % -176%
Operating Margin -6.66 % -76.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.8M shares +4.4%
Common Stock, Shares, Outstanding 26.7M shares +3.98%
Entity Public Float 80.2M USD -5.31%
Common Stock, Value, Issued 27K USD +3.85%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares +0.97%
Weighted Average Number of Shares Outstanding, Diluted 26.6K shares +3.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 39M USD +23.3%
Research and Development Expense 3.26M USD -2.02%
General and Administrative Expense 22.8M USD +20.2%
Operating Income (Loss) -2.6M USD -118%
Nonoperating Income (Expense) -1.21M USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.81M USD -453%
Income Tax Expense (Benefit) 15K USD -93.9%
Net Income (Loss) Attributable to Parent -3.82M USD -308%
Earnings Per Share, Basic -0.15 USD/shares -275%
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.9M USD -30.2%
Accounts Receivable, after Allowance for Credit Loss, Current 5.36M USD +57.2%
Inventory, Net 15.2M USD +1572%
Assets, Current 41M USD +52.8%
Property, Plant and Equipment, Net 34K USD -41.4%
Operating Lease, Right-of-Use Asset 175K USD +90.2%
Intangible Assets, Net (Excluding Goodwill) 34.9M USD +636%
Other Assets, Noncurrent 12K USD 0%
Assets 76.1M USD +140%
Accounts Payable, Current 4.17M USD +125%
Accrued Liabilities, Current 8.91M USD +65.5%
Liabilities, Current 19.9M USD +22.8%
Operating Lease, Liability, Noncurrent 107K USD +386%
Other Liabilities, Noncurrent 1.83M USD
Liabilities 51.7M USD +218%
Retained Earnings (Accumulated Deficit) -108M USD -3.67%
Stockholders' Equity Attributable to Parent 24.4M USD +57.8%
Liabilities and Equity 76.1M USD +140%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.47M USD -59.8%
Net Cash Provided by (Used in) Financing Activities -378K USD -671%
Net Cash Provided by (Used in) Investing Activities -1.88M USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 26.7M shares +3.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.73M USD -196%
Interest Paid, Excluding Capitalized Interest, Operating Activities 190K USD -12%
Deferred Tax Assets, Valuation Allowance 20.6M USD -4.31%
Deferred Tax Assets, Gross 21M USD -3.19%
Operating Lease, Liability 183K USD +144%
Depreciation 50K USD +13.6%
Payments to Acquire Property, Plant, and Equipment 14K USD
Lessee, Operating Lease, Liability, to be Paid 202K USD +149%
Property, Plant and Equipment, Gross 480K USD +5.96%
Operating Lease, Liability, Current 76K USD +43.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 90K USD +291%
Lessee, Operating Lease, Liability, to be Paid, Year One 89K USD +53.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19K USD +217%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23K USD
Deferred Tax Assets, Operating Loss Carryforwards 14.1M USD -8.43%
Unrecognized Tax Benefits 382K USD
Operating Lease, Payments 10K USD -54.5%
Amortization of Intangible Assets 1.1M USD +38.7%
Deferred Tax Assets, Net of Valuation Allowance 404K USD +139%
Share-based Payment Arrangement, Expense 2.38M USD -0.17%
Interest Expense 211K USD -21%